Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

Front Oncol. 2022 May 4:12:898576. doi: 10.3389/fonc.2022.898576. eCollection 2022.

Authors

Ruoning Yang^{1

2}, Haiyang Wang³, Xiaomeng Yin¹, Benjamin Frey⁴, Udo S Gaipl⁴, Hubing Shi¹, Xuelei Ma¹

Affiliations

¹ Department of Biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
² Department of Breast Surgery, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.
³ Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.
⁴ Translational Radiobiology, Universitätsklinikum Erlangen, Erlangen, Germany.

No abstract available

Keywords: editorial; immune-related adverse events (IRAEs); immunotherapy; lung cancer; management; pathogenesis.

Publication types

Editorial